TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Measurement of Systemic systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Heart Rate Display
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in HCV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in liver enzymes (ALT and AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CD4+ and CD8+ T-cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline in Frequency of Looking and Fixation Behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overactive Bladder Symptom Scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Low Back Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RNA-Expression pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: recovery rate of ovarian function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of participants that are satisfied with participation in the study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tumor stromal component
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usefulness of ICG fluorescence in guiding lymphadenectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change in Near-Infrared Fluorescence Lymphatic Imaging (NIRF-LI) assessment of lymphatic drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in cognitive test results as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS)-Global health( GH) scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in processing speed, as assessed by the Wechsler Adult Intelligence Scale -IV
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reporting turnaround time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in physical exam findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vulvovaginal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Relative change of PRO-C3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depressive Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Anxiety Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overall Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dynamic Q-angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention %
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of study measures including generation of mobile spirometry results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTD or Clinical recommended dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory mechanics indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: serum estradiol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sickness Simulator Questionnaire (SSQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in communication intentions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in planning intentions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Constant-Murley Score (CMS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum albumin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body Mass Index Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Immunoglobulin G (IgG) Antibody Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-reported mental health outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-reported psychosocial outcomes
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: self-reported physical health outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of pregnant women consuming five or more IFA/MMS tablets in the past week
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of pregnant women consuming 24 or more IFA/MMS tablets in the last 30 days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of pregnant women consuming 90 or more IFA/MMS tablets during the entire pregnancy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HIV viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virome Composition and Diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Host Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ICU scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone turnover markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Baseline of center of pressure displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of ASD procedure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Child sunscreen application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child hat wearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child wearing long sleeves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child shade seeking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarker rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Discharge Experience Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post Discharge Symptom Experience Risk Factor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Nocturnal Sleep Duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Percent Sleep Efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Subjective Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Local reactions (solicited adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: Systemic reactions (solicited adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: Seroresponse rate against SARS-CoV-2 ancestral (Wuhan) strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline self reported Depression Severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of melanocytes per mm2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of 24-hour heartburn-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: situational anxiety before session
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: situational anxiety after session
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exercise desaturation occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as assessed by NCI CTCAE v3.0
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of temsirolimus in combination with pazopanib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention (cognition)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Positive and negative affect (wellbeing)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Measure of CAM resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in the CORE-10 mood screen
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Montreal Cognitive Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in The Brain Injury Rehabilitation Trust Memory and Information Processing Battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of post-procedural acute pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Daily pain measured by NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engraftment of hematopoietic stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of subjects with AEs of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: gluteal projection ptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: waist hip ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction from surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Subjects With Major Vascular Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Subjects With Minor Vascular Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage change of myocardial infarction area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Zarit Care Burden Scale
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Changes in part 3 of Unified Parkinson Disease Rating Scale (UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of congenital anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in BCTQ scale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intervertebral bone fusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of adults with T1D achieving composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Successful implantation rate of intraocular lens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduced Use of Drug Using Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased Length of Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased (overall) Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of all treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of all TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of all treatment emergent serious adverse events (TE-SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of all TE-SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in CLIF-C ACLF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower limb movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: kinetics of lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate Uterine Tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change from Baseline Low Back Pain Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Freedom from documented VT episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Freedom from documented VT episodes after second intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-operative evidence of adenomyoma tissue ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall intervention satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of a humanoid robot
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Signal intensity of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: NRS-101
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implant mucosa health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Post Void Residual
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Referrals to behavioral health clinicians
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Specialty Treatment Initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Specialty Treatment Engagement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recurrent dislocation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total volume of fluid administered in 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Efficacy of antiviral treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving ≥4-point Improvement in Itch NRS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV care linkage/ART initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the ISS7 at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (CMAX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastrointestinal Health Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bowel Movement Diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants With Serious Adverse Events (SAEs) Within 7 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Pre-ablation Mapping and Clinically Indicated Mapping
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in vestibular function as measured by Functional Gait Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vestibular function as measured by Dizziness Handicap Inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in vestibular function as measured by I-PAS testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycaemic response (Matsuda index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average intestinal rates needed to fill ostomy pouch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Max intestinal rate following filling of ostomy pouch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants with Adverse Events (AEs) by Type and Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Bioequivalent ratio of calcium gluconate to calcium chloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance from first to second compartment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution of first compartment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tracking rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RP2D of SHR-9539 injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Material fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor Necrotizing Factor Alpha Serum Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Life of Cancer Patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life of Breast Cancer Patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life of Colorectal Cancer Patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in vaginal wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of malaria infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Simplified Functional Movement Disorders Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall treatment-adverse events rate
Endpoint domain: Adverse events/effects
Primary endpoint: Aδ ratio of amperage for sensory perception threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of neurogenic flare response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cycle control evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular High Luminance High Contrast logMAR Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CO2 reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Central apnea indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Low Back Pain Related Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum suPAR level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ART outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Native liver survival
Endpoint domain: Mortality/survival
Primary endpoint: Rate of adverse events (bleeding and hypotension)
Endpoint domain: Adverse events/effects
Primary endpoint: Child Anxiety Scale-Stateness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum comfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Participants' stated preference for care model
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of overall Quality of Life assessed by the WHOQOL-BREF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Quality of Life specified to Parkinson's Disease assessed by the PDQ-8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of PD-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertebro-Placental Ratio (VPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportions of patients with Adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of patients with Serious AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of patients with Adverse drug reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Neutralizing Antibody Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical validity of ctDNA tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Postpartum Hemorrhage (PPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Position of the impacted maxillary canine towards the dental midline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of hPG80
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wakefulness
Endpoint domain: Life impact
Endpoint subdomain: Sleep